Suchergebnisse - (Person:"Klonoff, David C")

PubPharm (4)

1

Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes : A post hoc analysis of the CONCLUDE trial

enthalten in: Diabetes, obesity & metabolism | 2022

von Pieber, T. | Bajaj, H. | Heller, S. | +7

2

Effect of insulin degludec versus insulin glargine U100 on time in range : SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia

enthalten in: Diabetes, obesity & metabolism | 2021

von Goldenberg, R. | Aroda, V. | Billings, L. | +7

CommentIn: MMW Fortschr Med. 2022 Mar;164(5):66. - PMID 35274276

3

The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized Trial

enthalten in: Journal of diabetes science and technology | 2021

von Billings, L. | Agner, B. | Altuntas, Y. | +5

4

Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes : the randomised, head-to-head CONCLUDE trial

enthalten in: Diabetologia | 2020

von Philis-Tsimikas, A. | Klonoff, D. | Khunti, K. | +8

CommentIn: Diabetologia. 2020 Apr;63(4):692-697. - PMID 31950229

1
[1]